These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32068508)

  • 1. Time to Clarify Common Misconceptions about the Liver Imaging Reporting and Data System for Contrast-enhanced US.
    Kono Y; Sirlin CB; Fetzer DT; Kim TK; Rodgers SK; Piscaglia F; Lyshchik A; Dietrich CF; Wilson SR
    Radiology; 2020 Apr; 295(1):245-247. PubMed ID: 32068508
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic accuracy of Magnetic Resonance Imaging using liver tissue specific contrast agents and contrast enhanced Multi Detector Computed Tomography: A systematic review of diagnostic test in Hepatocellular Carcinoma (HCC).
    Usman S; Smith L; Brown N; Major V
    Radiography (Lond); 2018 Nov; 24(4):e109-e114. PubMed ID: 30292515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common pitfalls when using the Liver Imaging Reporting and Data System (LI-RADS): lessons learned from a multi-year experience.
    Cannella R; Fowler KJ; Borhani AA; Minervini MI; Heller M; Furlan A
    Abdom Radiol (NY); 2019 Jan; 44(1):43-53. PubMed ID: 30073400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US.
    Lencioni R; Della Pina C; Crocetti L; Bozzi E; Cioni D
    Eur Radiol; 2007 Dec; 17 Suppl 6():F73-9. PubMed ID: 18376460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography - a prospective study.
    Boozari B; Soudah B; Rifai K; Schneidewind S; Vogel A; Hecker H; Hahn A; Schlue J; Dietrich CF; Bahr MJ; Kubicka S; Manns MP; Gebel M
    Dig Liver Dis; 2011 Jun; 43(6):484-90. PubMed ID: 21377941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.
    Lee SE; An C; Hwang SH; Choi JY; Han K; Kim MJ
    Eur Radiol; 2018 Apr; 28(4):1551-1559. PubMed ID: 29134355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
    Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
    Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hepatocellular carcinoma: An update on international guidelines.
    Cassinotto C; Aubé C; Dohan A
    Diagn Interv Imaging; 2017 May; 98(5):379-391. PubMed ID: 28395852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
    Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
    Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
    J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.
    Chernyak V; Fowler KJ; Kamaya A; Kielar AZ; Elsayes KM; Bashir MR; Kono Y; Do RK; Mitchell DG; Singal AG; Tang A; Sirlin CB
    Radiology; 2018 Dec; 289(3):816-830. PubMed ID: 30251931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of Atypical Hepatocellular Carcinoma from Focal Nodular Hyperplasia: Diagnostic Performance of Contrast-enhanced US and Microflow Imaging.
    Li W; Wang W; Liu GJ; Chen LD; Wang Z; Huang Y; Liu JY; Xie XY; Lu MD
    Radiology; 2015 Jun; 275(3):870-9. PubMed ID: 25584708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
    Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
    Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system.
    Kim TK; Noh SY; Wilson SR; Kono Y; Piscaglia F; Jang HJ; Lyshchik A; Dietrich CF; Willmann JK; Vezeridis A; Sirlin CB
    Clin Mol Hepatol; 2017 Dec; 23(4):280-289. PubMed ID: 28911220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group.
    Lyshchik A; Kono Y; Dietrich CF; Jang HJ; Kim TK; Piscaglia F; Vezeridis A; Willmann JK; Wilson SR
    Abdom Radiol (NY); 2018 Apr; 43(4):861-879. PubMed ID: 29151131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.